Literature DB >> 11481276

Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance.

T Kivelä1, S Eskelin, T Mäkitie, P Summanen.   

Abstract

PURPOSE: To determine independent predictors of exudative retinal detachment (RD) in eyes with uveal melanoma and the significance of RD in melanoma-specific survival.
METHODS: The extent of exudative RD was recorded retrospectively in a population-based cohort of 167 consecutive patients with eyes enucleated from 1972 through 1981 because of choroidal and ciliary body melanoma, representing all melanomas treated during that period. Histopathologic features including microvascular loops and networks, microvascular density (MVD), and tumor-infiltrating macrophages were determined. Clinical and histologic predictors of RD were modeled by multiple logistic regression with a split-sample, cross-validation design. Survival was assessed by Kaplan-Meier analysis and adjusted for the effect of competing predictors by Cox proportional hazards regression.
RESULTS: Of 142 (85%) eyes with adequate data, 25% had no RD, 16% had subretinal fluid around the tumor, 43% had clinical RD in one to two quadrants, and 16% had RD in three to four quadrants. The RD was more extensive if the tumor was large (P < 0.0001) and had microvascular loops and networks (P = 0.0094) and less extensive if it involved ciliary body (P = 0.011). High MVD (P = 0.054) and ruptured Bruch's membrane (P = 0.065) tended to be associated with RD. Multiple logistic regression showed largest basal diameter (odds ratio [OR] 1.43 for each 1-mm change, P < 0.0001), microvascular loops and networks (OR 1.95 for each category change, P = 0.0095), and ciliary body involvement (OR 0.20, P = 0.0039) to be independently associated with RD; ruptured Bruch's membrane (P = 0.96) and MVD (P = 0.87) were not associated. Clinical RD predicted poor survival (0.59 vs. 0.37 at 20 years; P = 0.029) by Kaplan-Meier analysis, but not after adjusting for other prognostic factors by Cox regression (hazard ratio [HR] 1.00, P = 1.0).
CONCLUSIONS: Tumor size, which may be a surrogate measure for total vascular content and decompensation of choriocapillaris and retinal pigment epithelium, is a strong predictor of exudative RD. Microvascular loops and networks are likewise associated with exudative RD. Exudative RD is not associated with survival after adjusting for tumor size and microvascular loops and networks.

Entities:  

Mesh:

Year:  2001        PMID: 11481276

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.

Authors:  Ilkka Puusaari; Bertil Damato; Tero Kivelä
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-18       Impact factor: 3.117

2.  Complete resection of isolated hepatic metastatic uveal melanoma with a notably long disease-free period: A case report and review of the literature.

Authors:  Shengzhang Lin; Dalong Wan; Haiyong Chen; Kangjie Chen; Shusen Zheng
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

3.  Endodrainage, Tumor Photocoagulation, and Silicone Oil Tamponade for Primary Exudative Retinal Detachment due to Choroidal Melanoma Persisting after Proton Beam Therapy.

Authors:  Ira Seibel; Dino Cordini; Gregor Willerding; Aline Isabel Riechardt; Antonia Maria Joussen
Journal:  Ocul Oncol Pathol       Date:  2014-07-22

4.  Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments.

Authors:  Devron H Char; Riley Bove; Theodore L Phillips
Journal:  Trans Am Ophthalmol Soc       Date:  2003

5.  Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II.

Authors:  David Miguel; Jesús María de Frutos-Baraja; Francisco López-Lara; María Antonia Saornil; Ciro García-Álvarez; Pilar Alonso; Patricia Diezhandino
Journal:  J Contemp Brachytherapy       Date:  2018-08-31

6.  Hidden Choroidal Melanoma Presented with Bullous Non-rhegmatogenous Retinal Detachment in a Myopic Asian Lady: A Rare Manifestation.

Authors:  Norihan Ibrahim; Zakariah Sakinah; Zulkifli Abdul Ghani; Mohtar Ibrahim
Journal:  Cureus       Date:  2019-03-27

7.  Uveal Melanoma and Secondary Angle-Closure Crisis: A Case Report and Literature Review.

Authors:  Tung Thanh Hoang; Tuan Anh Hoang; Peter McCluskey; John Grigg
Journal:  Case Rep Ophthalmol       Date:  2021-06-08

8.  Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment.

Authors:  Samuel K Houston; Nisha V Shah; Christina Decatur; Marcela Lonngi; William Feuer; Arnold M Markoe; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2013-01-22

9.  Breakdown of the blood-eye barrier in choroidal melanoma after proton beam radiotherapy.

Authors:  Annette Hager; Friederike Meissner; Aline-Isabel Riechardt; Theresa Bonaventura; Julia Löwen; Jens Heufelder; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-12       Impact factor: 3.117

10.  MRI enables accurate diagnosis and follow-up in uveal melanoma patients after vitrectomy.

Authors:  Myriam G Jaarsma-Coes; Teresa A Goncalves Ferreira; Guido R van Haren; Marina Marinkovic; Jan-Willem M Beenakker
Journal:  Melanoma Res       Date:  2019-12       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.